Hyosung expands global marketing team

Textile solutions provider appoints Claire O’Neill and Julia Nam as European Marketing Manager and US Marketing Manager, respectively

Claire O’Neill

To support its continued business growth and global expansion strategy, Hyosung has hired industry veteran, Claire O’Neill, as its new European Marketing Manager, and appointed Hyosung veteran, Julia Nam, in her new role within the company as US Marketing Manager, effective immediately.

O’Neill, who is based in the UK, has deep experience in the intimate, swim and global textile markets. She joins Hyosung from The Lycra Company, where she was most recently EMEA Brand Communications Manager, and previously, EMEA Marketing Segment Manager Lingerie, Underwear and Swimwear at Invista. At Hyosung, O’Neill will work with the company’s European marketing team in the promotion of Hyosung’s specialty fibers and fabrics to targeted brand and retail accounts. Additionally O’Neill will manage joint development and promotional programs with key industry partners.

Nam, whose most recent position with Hyosung was Marketing Manager, Intimates and Swim, has held many managerial roles with the company based in Seoul over her 19-year career with the company. As US Marketing Manager based in New York, NY, Nam will identify business opportunities and develop customized textile solutions to help US brands and retailers prosper.

Julia Nam

“Claire and Julia bring enormous resources to our team,” said Mike Simko, Global Marketing Director, Hyosung Textiles. “Their respective understanding of the global value chain, brand, retail and consumer needs, will help us further our global position as a major textile solution provider.”

With offices in more than 40 countries, Hyosung is able to locally support and interact with the international supply chain. Together with Hyosung’s Fashion Design Center (FDC) Team who forecast trends and create fabric stories and samples in the context of global trends, the Global Brand Marketing Team supports brands and retailers with design ideas, textile and product development – and then –  helps brands and retailers pull products made with Hyosung specialty fibers through to the consumer.

To provide faster product delivery and reduce its carbon footprint, Hyosung has strategically expanded its manufacturing network to serve clients on each continent since its start in Korea in 1992. In 1999, the company expanded into China, and now has bases in Vietnam for the rest of Asia, India for emerging Asian markets, Brazil for the Americas, and Turkey for Europe. The company recently invested in its Turkey and Brazil plant expansions and has its sights on further manufacturing development in the near future.

121 Replies to “Hyosung expands global marketing team

  1. The information on this page has been compiled for use by healthcare practitioners and consumers in the United States and therefore neither Everyday Health or its licensor warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise generic cialis vs cialis

  2. SIREDO French for Care, Innovation and research for children, adolescents and young adults with cancer gathers researchers and physicians in the oncopaediatrics, adolescent and young adult fields to bring new medications to patients as quickly as possible lasix liquido The RelB subunit of NFОєB acts as a negative regulator of circadian gene expression

  3. So I could have sent the patient to the dental extras priligy reviews Such exposure has not been reported to cause subsequent vaginal adenosis or clear cell carcinoma of the vagina or cervix in young women exposed in utero to Tamoxifen Arcana 20 mg

  4. It suggests that a dietary BSp regimen consumed during pregnancy lactation or from postnatal early life stage may render more efficacious effects on breast cancer prevention later in life than when consumed beginning from adulthood stromectol buy europe A traces before exposure

  5. cialis otc Although several recent clinical trials have allowed enrollment of men with breast cancer, the absolute number of MBC patients in any clinical trial is usually too small to draw meaningful conclusions about sex specific differences

Leave a Reply

Your email address will not be published.